Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Delaware Zantac Lawsuits Continue To Be Filed As GlaxoSmithKline Appeals to State Supreme Court Drug maker is challenging a lower court ruling, which allows Zantac lawsuits in Delaware to move forward to trial over the increased risk of cancer caused by the recalled heartburn medication. August 28, 2024 Irvin Jackson Add Your Comments The Delaware Supreme Court has agreed to hear an interlocutory appeal filed by GlaxoSmithKline (GSK), which seeks to overturn a lower court’s ruling that cleared the way for tens of thousands of Zantac lawsuits over cancers caused by the heartburn drug to be brought before juries in the state. The announcement that the highest court in the state will consider the appeal comes as a steady flow of new complaints continue to be filed in Delaware, where there are already more than 75,000 lawsuits pending that involve claims that Zantac caused users to develop bladder cancer, liver cancer, colon cancer, pancreatic cancer, stomach cancer and other injuries. The litigation emerged after all versions of Zantac were recalled from the market more than four years ago, following the discovery that the active pharmaceutical ingredient in the pills, ranitidine, is inherently unstable and produces high levels of the chemical byproduct N-Nitrosodimethylamine (NDMA), which is a known human carcinogen. Plaintiffs maintain that GSK and other drug makers knew or should have known about the Zantac cancer risks, yet failed to reformulate their products and continued to market the drug for treatment of heartburn and acid reflux for years. However, GSK is attempting to challenge the Delaware Zantac lawsuits by urging the state Supreme Court to exclude all plaintiffs’ expert witnesses from testifying under state-specific evidentiary standards. ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The Zantac litigation was initially focused in the federal court system, where claims brought in U.S. District Courts nationwide were centralized before U.S. District Judge Robin L. Rosenberg for coordinated discovery and pretrial proceedings. However, before the first federal case ever reached trial, Judge Rosenberg issued a controversial ruling determining that there was not sufficiently reliable expert testimony to establish that Zantact caused any cancer diagnosis among plaintiffs. Judge Rosenberg’s decision was based on an interpretation of the federal rules regarding the admissibility of expert testimony, resulting in the dismissal of all federal Zantac lawsuits. However, the ruling had no impact on claims that continued to be filed in various different state court systems, including Delaware, Illinois and Connecticut, where judges have already determined that different standards for the admissibility of expert witness testimony apply. GSK Appeals Approval of Delaware Zantac Lawsuits While a number of different drug makers have been involved in the development and sale of the drug, GSK probably faces the majority of Delaware Zantac lawsuits and has aggressively fought the litigation, while other manufacturers have already agreed to settle claims to resolve their liability. In June 2024, Delaware Judge Vivian L. Medinilla rejected GSK’s attempt to dismiss tens of thousands of Zantac lawsuits filed in the state, finding that the challenged expert witness testimony was sufficiently reliable to allow a jury to consider the case. GSK filed a petition to the Supreme Court of Delaware, seeking certification of an interlocutory appeal, which would allow the drug maker to challenge the ruling before any final judgment is entered in individual Zantac lawsuits pending in that state. In an order (PDF) issued on August 27, Justice N. Christopher Griffiths granted the request for an immediate appeal, indicating that resolving the issue could be dispositive for nearly 75,000 Delaware Zantac lawsuits currently pending, as well as the continuing new claims that are being filed by former users diagnosed with cancer. “GSK plc welcomes today’s decision by the Delaware Supreme Court that it will review the Delaware Superior Court’s decision allowing the introduction of plaintiffs’ expert evidence at trial,” the company wrote in a press release issued yesterday. “The scientific consensus remains that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer.” According to a schedule (PDF) issued by Delaware Supreme Court clerk Joanne K. Hastings on August 27, GSK’s opening brief must be filed by October 1, 2024, with any answers due 30 days later, and GSK’s final reply must be filed within 15 days after that. Delaware Zantac Lawsuits Continue to Be Filed While the parties await a ruling by the Delaware Supreme Court, plaintiffs continue to file new Zantac lawsuits in Delaware on a daily basis, each raising similar allegations that users developed cancers following long-term use of the heartburn drug. In one complaint (PDF) filed on August 19, Thomas Theys indicates that he developed prostate cancer as a result of using Zantac for just one year, from 2004 to 2005. In another complaint (PDF) filed the following day, Betty Jean Gross indicates that she developed esophageal cancer and prostate cancer after exposure to NDMA in Zantac, which she took from approximately 2013 until 2019. Both complaints maintain that GSK and other makers of generic versions of Zantac, including Boehringer Ingelheim, knew about the potential risks of Zantac cancer but consciously failed to warn the medical community and patients to protect profits. Tags: Cancer, Delaware, GlaxoSmithKline, Heartburn, Heartburn Drug, NDMA, Zantac, Zantac Recall Image Credit: Tada Images More Zantac Lawsuit Stories Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers October 10, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)
GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers October 10, 2024
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)